Oestrogen and stroke in women: assessment of risk (Q36292523)

13 August 2017

1 reference

title

Oestrogen and stroke in women: assessment of risk (English)

1 reference

13 August 2017

1 reference

Cheryl D Bushnell

1 reference

13 August 2017

publication date

1 November 2005

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

743-751

1 reference

Investigation of Relation between Use of Oral Contraceptives and Thromboembolic Disease. A Further Report

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Case-control study of oral contraceptives and risk of thromboembolic stroke: results from international study on oral contraceptives and health of young women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Stroke in users of low-dose oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Oral contraception and stroke. Evidence from the Royal College of General Practitioners' Oral Contraception Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Cerebral thrombosis and oral contraceptives. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Risk of ischemic stroke among users of the oral contraceptive pill: The Melbourne Risk Factor Study (MERFS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Ischemic stroke risk with oral contraceptives: A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Hormone replacement therapy and stroke risk in older women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Hormone replacement therapy and risk of non-fatal stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Hormone replacement therapy and associated risk of stroke in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Estrogen use and stroke risk in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Lifestyle factors and risk of cerebrovascular disease in women. The Copenhagen City Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Increased risk of stroke in hypertensive women using hormone therapy: analyses based on the Danish Nurse Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

A clinical trial of estrogen-replacement therapy after ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Understanding the divergent data on postmenopausal hormone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Prior to use of estrogen replacement therapy, are users healthier than nonusers?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Cardiovascular effects of 6 months of hormone replacement therapy versus placebo: differences associated with years since menopause

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Neuroprotective effects of female gonadal steroids in reproductively senescent female rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Estradiol exerts neuroprotective effects when administered after ischemic insult

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Estrogen and stroke: a balanced analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Hormone replacement therapy, inflammation, and hemostasis in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

The effect of different doses of micronized 17beta-estradiol on C-reactive protein, interleukin-6, and lipids in older women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Does the type of hormone replacement therapy affect lipoprotein (a), homocysteine, and C-reactive protein levels in postmenopausal women?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Acute vascular effects of estrogen in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

The Role of Nitric Oxide in Coronary Vascular Effects of Estrogen in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Vascular effects of estrogen in type II diabetic postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Hormone therapy impairs endothelial function in postmenopausal women with type 2 diabetes mellitus treated with rosiglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Effect of hormone replacement therapy on carotid arterial compliance in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Hormone replacement therapy and distensibility of carotid arteries in postmenopausal women: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

No association of menopause and hormone replacement therapy with carotid artery intima-media thickness. Atherosclerosis Risk in Communities (ARIC) Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Effects of hormone replacement therapy on blood coagulation and fibrinolysis in hypertensive and normotensive postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Postmenopausal hormone replacement therapy increases plasmatic thromboxane beta 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Estrogen replacement therapy, thrombophilia, and atherothrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Genetic variants of platelet glycoprotein receptors and risk of stroke in young women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

The puzzle of aspirin and sex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970220-9

7 January 2021

10.1016/S1474-4422(05)70220-9

Identifiers

DOI

1 reference

13 August 2017

1 reference